TGFB1 and hepatocellular carcinoma: Based on these data, TGF-β signaling is a potential target for the treatment of HCC, and the direct inhibition of TGF-β signaling has been demonstrated to have therapeutic effects on HCC both in vitro and in vivo18, 22, 23, 24.